Abcam Plc (LON:ABC)‘s stock had its “sell” rating reissued by equities researchers at Panmure Gordon in a research note issued to investors on Thursday.

A number of other research firms also recently commented on ABC. Numis Securities Ltd restated an “add” rating and set a GBX 1,116 ($14.54) price objective on shares of Abcam Plc in a research note on Thursday. Stifel Nicolaus restated a “hold” rating and set a GBX 890 ($11.59) price objective on shares of Abcam Plc in a research note on Tuesday, April 4th. Finally, Berenberg Bank assumed coverage on shares of Abcam Plc in a research note on Tuesday, June 27th. They set a “buy” rating and a GBX 1,100 ($14.33) price objective for the company. One research analyst has rated the stock with a sell rating, four have given a hold rating and one has assigned a buy rating to the company’s stock. Abcam Plc presently has a consensus rating of “Hold” and a consensus price target of GBX 900 ($11.72).

Abcam Plc (LON:ABC) traded up 1.90% during mid-day trading on Thursday, reaching GBX 1021.00. The company had a trading volume of 403,803 shares. Abcam Plc has a 52-week low of GBX 714.00 and a 52-week high of GBX 1,025.00. The stock’s market capitalization is GBX 2.06 billion. The company’s 50 day moving average is GBX 975.28 and its 200 day moving average is GBX 895.25.

COPYRIGHT VIOLATION NOTICE: This news story was originally reported by American Banking News and is the sole property of of American Banking News. If you are accessing this news story on another domain, it was stolen and republished in violation of US and international trademark & copyright law. The original version of this news story can be accessed at

In other Abcam Plc news, insider Mara G. Aspinall acquired 2,700 shares of Abcam Plc stock in a transaction dated Monday, June 5th. The stock was bought at an average cost of GBX 979 ($12.75) per share, for a total transaction of £26,433 ($34,435.90).

Abcam Plc Company Profile

Abcam plc is a global life sciences company. As a developer of reagents and tools, the Company’s purpose is to serve life science researchers globally. Providing the research and clinical communities with tools and scientific support, the Company offers validated biological binders and assays to address important targets in critical biological pathways.

Analyst Recommendations for Abcam Plc (LON:ABC)

Receive News & Ratings for Abcam Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abcam Plc and related companies with's FREE daily email newsletter.